# Avanir Pharmaceuticals (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/avanir-pharmaceuticals-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 4 |
| Citations | 13,462 |
| City | Aliso Viejo |
| Country | US |
| Description | Avanir Pharmaceuticals (United States) is a research organisation in Aliso Viejo, US. OpenAlex records 251 works and 13,462 citations for it. 46 researchers list it as their most recent affiliation. |
| Homepage | http://www.avanir.com/ |
| OpenAlex ID | https://openalex.org/I4210127237 |
| Researchers | 46 |
| ROR ID | https://ror.org/02z28nb98 |
| Type | company |
| Works | 251 |

## University papers

- [The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial](https://scholariq.org/papers/the-combination-of-aroxybutynin-and-atomoxetine-in-the-treatment-of-obstructive/)
- [NightBalance Sleep Position Treatment Device Versus Auto-Adjusting Positive Airway Pressure for Treatment of Positional Obstructive Sleep Apnea](https://scholariq.org/papers/nightbalance-sleep-position-treatment-device-versus-auto-adjusting-positive/)
- [Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA](https://scholariq.org/papers/combination-of-atomoxetine-with-the-novel-antimuscarinic-aroxybutynin-improves/)
- [RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates](https://scholariq.org/papers/restore-once-nightly-oxybate-dosing-preference-and-nocturnal-experience-with/)
- [Sleepiness in healthcare workers](https://scholariq.org/papers/sleepiness-in-healthcare-workers/)
- [0538 Mariposa: Oral Therapy AD109 Improves Objective & Patient Reported Outcomes In OSA. Randomized, Placebo Controlled Clinical Trial](https://scholariq.org/papers/0538-mariposa-oral-therapy-ad109-improves-objective-and-amp-patient-reported/)
- [0589 Dose Titration of Once-Nightly Sodium Oxybate: Analysis of Interim Data From RESTORE](https://scholariq.org/papers/0589-dose-titration-of-once-nightly-sodium-oxybate-analysis-of-interim-data-from/)
- [0732 Drug Class Utilization and Age-Related Trends in Narcolepsy and Idiopathic Hypersomnia: A Claims Database Analysis](https://scholariq.org/papers/0732-drug-class-utilization-and-age-related-trends-in-narcolepsy-and-idiopathic/)
- [0411 Once-Nightly Sodium Oxybate Dose Titration and Tolerability: Interim Data From RESTORE](https://scholariq.org/papers/0411-once-nightly-sodium-oxybate-dose-titration-and-tolerability-interim-data/)
- [DOSE TITRATION AND TOLERABILITY OF ONCE-NIGHTLY SODIUM OXYBATE: INTERIM DATA FROM RESTORE](https://scholariq.org/papers/dose-titration-and-tolerability-of-once-nightly-sodium-oxybate-interim-data-from/)
- [RELATIVE PREVALENCE OF IDIOPATHIC HYPERSOMNIA, NARCOLEPSY TYPE 1, AND NARCOLEPSY TYPE 2: A CLAIMS DATABASE ANALYSIS](https://scholariq.org/papers/relative-prevalence-of-idiopathic-hypersomnia-narcolepsy-type-1-and-narcolepsy/)

## University researchers

- [Brian Abaluck](https://scholariq.org/researchers/brian-abaluck/)

## University top topics

Showing 8 of 25.

- [Sleep and Wakefulness Research](https://scholariq.org/topics/sleep-and-wakefulness-research/)
- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Sleep and related disorders](https://scholariq.org/topics/sleep-and-related-disorders/)
- [Restless Legs Syndrome Research](https://scholariq.org/topics/restless-legs-syndrome-research/)
- [Dysphagia Assessment and Management](https://scholariq.org/topics/dysphagia-assessment-and-management/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Sleep and Work-Related Fatigue](https://scholariq.org/topics/sleep-and-work-related-fatigue/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.